Short answer
Janux Therapeutics, Inc. (JANX) filed an 8-K current report with the SEC on May 7, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Janux reported financial results for the three months ended March 31, 2026.
Janux Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Janux reported financial results for the three months ended March 31, 2026
- Press release containing results attached as Exhibit 99.1
- Information furnished under Regulation FD, not filed under Exchange Act Section 18 liability rules
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Janux Therapeutics, Inc. 8-K filings
Get the next JANX 8-K as it lands
Follow JANX for push alerts, or ask the research agent what this filing means.